Skip to main content


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Full Schedule

Full Schedule

  • Friday, April 5, 2024
  • 6:30 AM – 7:30 AM ET
    Yoga
  • 7:00 AM – 8:00 AM ET
    CE Symposium: Maximizing Efficacy and Minimizing Toxicity of ADCs Targeting HER2, HER3 and TROP2: Strategies for Oncology Pharmacists
  • 7:00 AM – 8:00 AM ET
    CE Symposium: Navigating Chronic Lymphocytic Leukemia Therapy and Cardiovascular Comorbidities: Clinical Recommendations and Safety Measures
  • 7:00 AM – 8:00 AM ET
    CE Symposium: Optimizing Bispecific Antibody Utilization in Non-Hodgkin Lymphoma: Addressing Challenges in Community-Based Care
  • 7:00 AM – 8:00 AM ET
    Special Interest Group (SIG) - Ambulatory
  • 7:00 AM – 8:00 AM ET
    Special Interest Group (SIG) - Breast Cancer
  • 7:00 AM – 8:00 AM ET
    Special Interest Group (SIG) - Cerner Oncology Users
  • 7:00 AM – 8:00 AM ET
    Special Interest Group (SIG) - Industry Professionals
  • 8:15 AM – 9:30 AM ET
    New Flavors: Bites in Hematologic Malignancies
  • 8:15 AM – 9:30 AM ET
    Pharmacology and Clinical Application of Complement Inhibitors
  • 9:40 AM – 10:40 AM ET
    1 - Ethical Dilemmas in Oncology Pharmacy: When Science and Morals Collide
  • 9:40 AM – 10:40 AM ET
    2 - The Gene Therapy Odyssey: Preparing the Pharmacist for New Horizons
  • 9:40 AM – 10:40 AM ET
    3 - Bispecifics in Lymphoma
  • 9:40 AM – 10:40 AM ET
    4 - Taking a Bite Out of Myeloma: The Role of Bi-Specific Antibodies in the Treatment of Relapsed/Refractory Multiple Myeloma
  • 9:40 AM – 10:40 AM ET
    5 - Updates in the Management of Endometrial Cancer
  • 9:40 AM – 10:40 AM ET
    6 - Expanding the Use of CDK4/6 Inhibitors to Early-Stage Breast Cancer Treatment
  • 10:50 AM – 11:50 AM ET
    John G. Kuhn Keynote Address: Dr. Glaucomflecken "Wife & Death & Comedy"
  • 11:50 AM – 2:15 PM ET
    Exhibit Hall and Lunch
  • 12:00 PM – 1:00 PM ET
    Non-CE Symposium: Explore the current data that could help you recognize/assess candidates for a CDK4 & 6 inhibitor.
  • 12:00 PM – 1:00 PM ET
    Non-CE Symposium: Practical Management of AML with a BCL-2 Inhibitor
  • 12:00 PM – 1:00 PM ET
    Non-CE Symposium: Understanding the role of pharmacists in the management of Low-risk Myelodysplastic Syndromes (MDS)
  • 12:00 PM – 1:00 PM ET
    Special Interest Group (SIG) - Classical Hematology
  • 12:00 PM – 1:00 PM ET
    Special Interest Group (SIG) - Investigational Drug Services (IDS)
  • 12:00 PM – 1:00 PM ET
    Special Interest Group (SIG) - Residency Program Directors (RPD)
  • 12:00 PM – 1:00 PM ET
    Special Interest Group (SIG) - Trainee
  • 12:00 PM – 2:00 PM ET
    Poster Session: Trainee Research
  • 2:15 PM – 3:00 PM ET
    Incoming President's Remarks
  • 3:15 PM – 4:15 PM ET
    Aiming for the Bullseye: Updates in Pediatric Solid Tumor Precision Medicine
  • 3:15 PM – 4:15 PM ET
    Buzzworthy Bladder Breakthroughs: Updates in Metastatic Bladder Cancer
  • 6:00 PM – 9:00 PM ET
    HOPA's 20th Anniversary Gala